RESCUE and REVERSE Long-term Follow-up
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Nancy Newman, MD
Emory University Hospital Atlanta, Georgia, United States, 30322
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chno Les Quinze Vingts
Paris, France
- Lmu Klinikum Der Universität München / Friedrich-Baur-Institut
Munich, Germany
- Ospedale Bellaria
Bologna, Italy
- Moorfields Eye Hospital
London, Greater London, United Kingdom
- Doheny Eye Center Ucla
Pasadena, California, United States
- Emory University Hospital
Atlanta, Georgia, United States
- Wills Eye Institute
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Jan 2018
- Primary completion
- 4 Jul 2022
- Completion
- 4 Jul 2022
- Last update posted
- 2 Mar 2026
- Registered enrollment
- 62
- Registry id
- NCT03406104
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.